Article
Wednesday, September 27th, 2006Here’s a new article I just found:
Byetta: A multi-pronged approach to glucose control
In April 2005 the FDA approved Byetta, an injectable medication, as an adjunct
treatment for adults with Type 2 diabetes who cannot achieve good glucose
control with oral medications such as metformin, a sulfonylurea or a combination
of these medicines. Some people will find the improved glucose control and
weight loss worth the twice-daily injections.
What it does: Byetta works on several organ systems affected by diabetes: It
increases insulin secretion from the pancreas, decreases glucose release from
the liver, lessens glucose absorption by slowing digestion and curbs appetite.
The medication has been found to reduce A1C levels moderately, about one
percent. And though Byetta may produce some weight loss, it is not prescribed
for that indication.
(more…)